Sökning: onr:"swepub:oai:DiVA.org:umu-181536" > Impact of the COVID...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 08895naa a2200937 4500 | |
001 | oai:DiVA.org:umu-181536 | |
003 | SwePub | |
008 | 210401s2021 | |||||||||||000 ||eng| | |
009 | oai:lup.lub.lu.se:66af8b9e-8984-46ed-b347-d61bd9841f82 | |
009 | oai:DiVA.org:liu-178269 | |
009 | oai:DiVA.org:uu-452378 | |
009 | oai:prod.swepub.kib.ki.se:147182236 | |
009 | oai:gup.ub.gu.se/302600 | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-1815362 URI |
024 | 7 | a https://doi.org/10.1136/annrheumdis-2021-2198452 DOI |
024 | 7 | a https://lup.lub.lu.se/record/66af8b9e-8984-46ed-b347-d61bd9841f822 URI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-1782692 URI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4523782 URI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1471822362 URI |
024 | 7 | a https://gup.ub.gu.se/publication/3026002 URI |
040 | a (SwePub)umud (SwePub)lud (SwePub)liud (SwePub)uud (SwePub)kid (SwePub)gu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Bower, Hannahu Karolinska Institutet,Karolinska Institute,Karolinska Inst, Dept Med Solna, Stockholm, Sweden.4 aut |
245 | 1 0 | a Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population :b a nationwide Swedish cohort study |
264 | c 2021-02-23 | |
264 | 1 | b BMJ Publishing Group Ltd,c 2021 |
338 | a electronic2 rdacarrier | |
500 | a Funding Agencies|Swedish research CouncilSwedish Research CouncilEuropean Commission; Swedish Heart-Lung foundationSwedish Heart-Lung Foundation; Swedish Cancer SocietySwedish Cancer Society; NordForsk; Foundation for Research in Rheumatology (FOREUM); Region Stockholm; Karolinska Institutet (ALF)Karolinska Institutet | |
520 | a Objectives: To estimate absolute and relative risks for all-cause mortality and for severe COVID-19 in inflammatory joint diseases (IJDs) and with antirheumatic therapies.Methods: Through Swedish nationwide multiregister linkages, we selected all adult patients with rheumatoid arthritis (RA, n=53 455 in March 2020), other IJDs (here: spondyloarthropathies, psoriatic arthritis and juvenile idiopathic arthritis, n=57 112), their antirheumatic drug use, and individually matched population referents. We compared annual all-cause mortality March-September 2015 through 2020 within and across cohorts, and assessed absolute and relative risks for hospitalisation, admission to intensive care and death due to COVID-19 March-September 2020, using Cox regression.Results: During March-September 2020, the absolute all-cause mortality in RA and in other IJDs was higher than 2015-2019, but relative risks versus the general population (around 2 and 1.5) remained similar during 2020 compared with 2015-2019. Among patients with IJD, the risks of hospitalisation (0.5% vs 0.3% in their population referents), admission to intensive care (0.04% vs 0.03%) and death (0.10% vs 0.07%) due to COVID-19 were low. Antirheumatic drugs were not associated with increased risk of serious COVID-19 outcomes, although for certain drugs, precision was limited.Conclusions: Risks of severe COVID-19-related outcomes were increased among patients with IJDs, but risk increases were also seen for non-COVID-19 morbidity. Overall absolute and excess risks are low and the level of risk increases are largely proportionate to those in the general population, and explained by comorbidities. With possible exceptions, antirheumatic drugs do not have a major impact on these risks. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Allmänmedicin0 (SwePub)302242 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex General Practice0 (SwePub)302242 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Reumatologi och inflammation0 (SwePub)302102 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Rheumatology and Autoimmunity0 (SwePub)302102 hsv//eng |
653 | a arthritis | |
653 | a biological therapy | |
653 | a Covid-19 | |
653 | a epidemiology | |
653 | a health care | |
653 | a outcome assessment | |
653 | a rheumatoid | |
653 | a arthritis | |
653 | a biological therapy | |
653 | a Covid-19 | |
653 | a epidemiology | |
653 | a health care | |
653 | a outcome assessment | |
653 | a rheumatoid | |
700 | 1 | a Frisell, Thomasu Karolinska Institutet,Karolinska Institute,Karolinska Inst, Dept Med Solna, Stockholm, Sweden.4 aut |
700 | 1 | a Di Giuseppe, Danielau Karolinska Institutet,Karolinska Institute,Karolinska Inst, Dept Med Solna, Stockholm, Sweden.4 aut |
700 | 1 | a Delcoigne, Bénédicteu Karolinska Institutet,Karolinska Institute,Karolinska Inst, Dept Med Solna, Stockholm, Sweden.4 aut |
700 | 1 | a Alenius, Gerd-Marie,c Docent,d 1957-u Umeå University,Umeå universitet,Reumatologi,Umeå Univ, Dept Publ Hlth & Clin Med, Rheumatol Unit, Umeå, Sweden.4 aut0 (Swepub:umu)geal0001 |
700 | 1 | a Baecklund, Eva,d 1956-u Uppsala universitet,Uppsala University,Uppsala Univ, Sweden,Reumatologi4 aut0 (Swepub:uu)evaba786 |
700 | 1 | a Chatzidionysiou, Katerinau Karolinska Institutet,Karolinska Institute,Karolinska Inst, Dept Med Solna, Stockholm, Sweden.4 aut |
700 | 1 | a Feltelius, Nilsu Swedish Medical Products Agency, Uppsala, Sweden,Swedish Med Prod Agcy, Uppsala, Sweden.4 aut |
700 | 1 | a Forsblad d'Elia, Helena,d 1961u Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för reumatologi och inflammationsforskning,Institute of Medicine, Department of Rheumatology and Inflammation Research4 aut0 (Swepub:gu)xforhe |
700 | 1 | a Kastbom, Alfu Linköpings universitet,Linköping University,Avdelningen för inflammation och infektion,Medicinska fakulteten,Region Östergötland, Reumatologiska kliniken i Östergötland,Linköping Univ, Dept Biomed & Clin Sci, Linköping, Sweden.4 aut0 (Swepub:liu)alfka05 |
700 | 1 | a Klareskog, Larsu Karolinska Institutet,Karolinska Institute,Karolinska Inst, Dept Med Solna, Stockholm, Sweden.4 aut |
700 | 1 | a Lindqvist, Elisabetu Lund University,Lunds universitet,Lund Arthritis Research Group (LARG),Forskargrupper vid Lunds universitet,Lund University Research Groups,Lund Univ, Dept Clin Sci, Lund, Sweden.4 aut0 (Swepub:lu)reum-eli |
700 | 1 | a Lindström, Ulfu Gothenburg University,Göteborgs universitet,University of Gothenburg,Sahlgrenska Academy,Univ Gothenburg, Sahlgrenska Acad, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden.,Institutionen för medicin, avdelningen för reumatologi och inflammationsforskning,Institute of Medicine, Department of Rheumatology and Inflammation Research4 aut0 (Swepub:gu)xlulfn |
700 | 1 | a Turesson, Carlu Lund University,Lunds universitet,Reumatologi,Forskargrupper vid Lunds universitet,Rheumatology,Lund University Research Groups,Lund Univ, Dept Clin Sci, Rheumatol, Malmö, Sweden.4 aut0 (Swepub:lu)med-ctn |
700 | 1 | a Sjöwall, Christopheru Linköpings universitet,Linköping University,Avdelningen för inflammation och infektion,Medicinska fakulteten,Region Östergötland, Reumatologiska kliniken i Östergötland,Linköping Univ, Dept Biomed & Clin Sci, Linköping, Sweden.4 aut0 (Swepub:liu)chrsj93 |
700 | 1 | a Askling, Johanu Karolinska Institutet,Karolinska Institute,Karolinska Inst, Dept Med Solna, Stockholm, Sweden.4 aut |
710 | 2 | a Karolinska Instituteb Karolinska Inst, Dept Med Solna, Stockholm, Sweden.4 org |
710 | 2 | a ARTIS Study Group |
773 | 0 | t Annals of the Rheumatic Diseasesd : BMJ Publishing Group Ltdg 80:8, s. 1086-1093q 80:8<1086-1093x 0003-4967x 1468-2060 |
856 | 4 | u https://doi.org/10.1136/annrheumdis-2021-219845y Fulltext |
856 | 4 | u https://umu.diva-portal.org/smash/get/diva2:1541645/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 | u https://ard.bmj.com/content/annrheumdis/80/8/1086.full.pdf |
856 | 4 | u http://dx.doi.org/10.1136/annrheumdis-2021-219845x freey FULLTEXT |
856 | 4 | u https://liu.diva-portal.org/smash/get/diva2:1585566/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 | u https://uu.diva-portal.org/smash/get/diva2:1591549/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-181536 |
856 | 4 8 | u https://doi.org/10.1136/annrheumdis-2021-219845 |
856 | 4 8 | u https://lup.lub.lu.se/record/66af8b9e-8984-46ed-b347-d61bd9841f82 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-178269 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-452378 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:147182236 |
856 | 4 8 | u https://gup.ub.gu.se/publication/302600 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy